Burning Rock Biotech Ltd (BNR): Total Assets
820.38M CNY
As of 2025-12-31
-19.8%
3-year compound annual growth
-21.0%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 820.38M CNY | -7.3% | 2026-04-28, Balance as of period end |
| 2024-12-31 | 885.30M CNY | -14.9% | 2026-04-28, Balance as of period end |
| 2023-12-31 | 1.04B CNY | -34.5% | 2025-04-29, Balance as of period end |
| 2022-12-31 | 1.59B CNY | -30.3% | 2024-04-29, Balance as of period end |
| 2021-12-31 | 2.28B CNY | -14.4% | 2023-04-20, Balance as of period end |
| 2020-12-31 | 2.66B CNY | +214.2% | 2022-04-29, Balance as of period end |
| 2019-12-31 | 847.56M CNY | n/a | 2021-03-23, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Burning Rock Biotech Ltd (BNR) | 2025-12-31 | 820.38M CNY | -7.3% |
| Concord Medical Services Holdings Ltd (CCM) | 2025-12-31 | 6.55B CNY | -2.7% |
Compare BNR, CCM side by side · Screen every company in Services-Medical Laboratories ↗